| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |